Bruker Corporation Acquires Inscopix, Inc.
November 8, 2022
Bruker Corporation has acquired Inscopix, Inc., a Mountain View–based developer of miniaturized head-mounted microscopes (miniscopes) for freely moving animal brain imaging. The acquisition integrates Inscopix’s miniscope platform and analysis pipeline with Bruker’s preclinical imaging and multiphoton microscopy capabilities to expand Bruker’s in-vivo neural functional imaging offerings; financial terms were not disclosed.
- Buyers
- Bruker Corporation
- Targets
- Inscopix, Inc.
- Industry
- Medical Devices
- Location
- California, United States
- Transaction Type
- Buyout
Explore More
Related Acquisitions
-
Bruker Corporation Acquires biocrates life sciences ag
June 3, 2025
Biotechnology
Bruker Corporation has acquired biocrates life sciences ag, an Innsbruck, Austria-based leader in mass-spectrometry-based quantitative metabolomics. The deal adds biocrates' metabolomics kits, assays, software and contract research services to Bruker's multiomics strategy, expanding Bruker's MS-based metabolomics and integrated multiomics capabilities. Financial terms were not disclosed.
-
Bruker Corporation Acquires NanoString Technologies Business
May 6, 2024
Medical Devices
Bruker Corporation has acquired substantially all assets of NanoString Technologies, Inc. through a court-supervised Chapter 11 asset sale for approximately $392.6 million in cash plus assumption of certain liabilities. The deal, announced April 2024 and closed in late April/early May 2024, brings NanoString's spatial biology and gene-expression product lines into Bruker to preserve customer access, product development, and jobs while expanding Bruker's life‑science instrumentation capabilities.
-
Bruker Corporation Acquires Spectral Instruments Imaging
February 6, 2024
Medical Devices
Bruker Corporation has acquired Spectral Instruments Imaging LLC, a Tucson-based maker of preclinical in‑vivo optical imaging systems, to broaden Bruker BioSpin's preclinical imaging portfolio. Financial terms were not disclosed; SII generated over $10 million in revenue in 2023 and will expand Bruker's capabilities in bioluminescence, fluorescence and X‑ray preclinical imaging.
-
Bruker Corporation to Acquire PhenomeX Inc for $108 Million
August 17, 2023
Medical Devices
Bruker Corporation has signed a definitive agreement to acquire PhenomeX Inc in an all-cash transaction valued at approximately $108 million equity value ($1.00 per share). The deal is expected to close in the fourth quarter of 2023, subject to customary closing conditions, after which PhenomeX will merge into a wholly owned Bruker subsidiary.
-
Bruker Corporation to Acquire Neurescence Inc.
November 12, 2022
Healthcare Services
Bruker Corporation has signed a definitive agreement to purchase 100% of the shares of Neurescence Inc., an ultralight fiber-bundle Multiscopes provider for simultaneous multi-region optical functional neuroimaging. The acquisition is expected to create synergies with Bruker’s multiphoton and head-mounted miniscope offerings, expanding its reach in freely behaving animal imaging and photostimulation.
-
Bruker Corporation Acquires Canopy Biosciences, LLC
September 11, 2020
Biotechnology
Bruker Corporation has acquired Canopy Biosciences, LLC to strengthen its targeted multi-omics and high-plex biomarker imaging capabilities, adding Canopy's ChipCytometry platform and multi-omics services. Financial terms were not disclosed; Ampersand Capital Partners was identified as Canopy's lead investor.
Build a buyer list for your deal
Find active buyers from recent acquisition patterns and move straight into outreach.